Completed
A Pilot Study to Assess the Immunogenicity and Reactogenicity of High Versus Standard Dose TIV
NCT02263040
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- Mount Sinai Hospital Toronto, Ontario, Canada